Stacking the two can also provide optimal benefits
For instance, in NSCLC, treatment with first- and second-generation EGFR tyrosine kinase inhibitors (TKIs) often leads to the development of the EGFR T790M mutation, while third-generation inhibitors subsequently select for the C797S mutation, both of which confer resistance
[16] These remain areas of investigation in humans and should not be interpreted as established risks at this stage
Cytosolic GSTs are classified on the basis of sequence similarities and structural properties
In experimental models, BPC-157 has been observed to accelerate wound healing , stimulate collagen synthesis , and enhance angiogenesis through upregulation of growth factors such as VEGF and modulation of the FAK-paxillin signaling pathway
Potential side effects are generally mild (e.g., bloating or digestive upset) when taken in recommended doses